NCT00463151View on ClinicalTrials.gov

An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Colitis, Ulcerative
Interventions
DRUG

rebamipide

0, 60, 150, 300mg of rebamipide per day for 6 weeks into colon

Trial Locations (5)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kinki Region

Kyushu Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY